Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Anterior Segment > Study highlights GATT as a promising option for failed glaucoma surgeries
  • Anterior Segment

Study highlights GATT as a promising option for failed glaucoma surgeries

Kelsey Moroz

Gonioscopy-assisted transluminal trabeculotomy (GATT) is an effective and safe surgical option for managing intraocular pressure (IOP) in patients who have previously experienced failures with other glaucoma surgeries, according to a study.

The retrospective study evaluated the efficacy of GATT in 30 eyes of patients who had previously undergone unsuccessful glaucoma surgeries. All participants had open angles on gonioscopy and experienced failure with prior glaucoma interventions.

The study found that GATT significantly reduced IOP from an average of 27.1 mm Hg to 16.9 mm Hg over 15 months.

Success rates varied, with a complete success rate of 20% at 1 year based on IOP criteria of 16 mm Hg and 82% for an IOP criterion of 21 mm Hg. Qualified success rates were 57% and 82% at 1 year, respectively.

The average age of patients was 51.8 years, and risk factors for failure included older age. Of note, 46% of eyes experienced hyphema, though this condition resolved without intervention in all cases.

Reference
Siddhartha S, Krishnamurthy R, Dikshit S, Garudadri C, Ali MH, Senthil S. Outcomes of Gonioscopy-Assisted Transluminal Trabeculotomy in Eyes With Prior Failed Glaucoma Surgery. J Glaucoma. 2024;33(8):612-617. doi: 10.1097/IJG.0000000000002414. Epub 2024 May 6. PMID: 39141408.

Share

Related Content

  • Glaucoma

Study finds significant IOP reductions with iDose TR and MIGS procedures

  • Glaucoma

EyeValve device lowers IOP and maintains control for 9 months in first-in-human study

  • Glaucoma

GLP-1 therapies may offer potential benefits in glaucoma

  • Glaucoma

PreserFlo MicroShunt shows short-term benefit in refractory childhood glaucoma

  • Glaucoma

iStent adoption rises as surgeons treat glaucoma earlier

  • Glaucoma

Review finds low adverse event rates for glaucoma stents

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon